Table 2.
Parameters | Treatment | |||
---|---|---|---|---|
CT | MLT | MHT | AT | |
Growth Performance | ||||
Initial Body Weight, g | 9.45 ± 0.15 | 8.92 ± 0.26 | 9.26 ± 0.20 | 8.98 ± 0.16 |
Final Body Weight, g | 17.8 ± 0.26 | 17.62 ± 0.35 | 17.77 ± 0.23 | 17.22 ± 0.14 |
ADG, g | 441.0 ± 5.67 a | 462.81 ± 5.40 b | 447.8 ± 1.89 ab | 433.68 ± 1.90 a |
ADFI, g | 737.59 ± 7.65 | 729.4 ± 10.54 | 736.47 ± 8.96 | 712.94 ± 2.70 |
F/G, g/g | 1.670 ± 0.004 b | 1.576 ± 0.012 a | 1.640 ± 0.011 ab | 1.640 ± 0.012 ab |
Immune organ Indexes | ||||
Thymus Index | 2.59 ± 0.15 a | 2.94 ± 0.04 ab | 3.15 ± 0.15 b | 2.61 ± 0.08 a |
Spleen Index | 1.69 ± 0.04 a | 1.90 ± 0.07 b | 1.90 ± 0.06 b | 1.87 ± 0.09 b |
Treatments: Control treatment (CT), basal diet (BD); MLP low-dose treatment (MLT), 0.6 g/kg MLPs + BD; MLP high-dose treatment (MHT), 1.2 g/kg MLPs + BD; antibiotic treatment (AT), 0.15 g/kg aureomycin + BD. Values are expressed as means ± SEM, N = 5; a, b Means with different superscripts differ significantly (P < 0.05).